Results 151 to 160 of about 142,698 (173)
Some of the next articles are maybe not open access.
Planta Medica, 2002
Silymarin, a mixture of flavonolignans isolated from Silybum marianum, is known for its hepatoprotective properties. We investigated the expression of cytokines in mouse liver following treatment with 0, 10, 50, and 250 mg/kg of silymarin once daily for 5 days.
Quanren, He +3 more
openaire +2 more sources
Silymarin, a mixture of flavonolignans isolated from Silybum marianum, is known for its hepatoprotective properties. We investigated the expression of cytokines in mouse liver following treatment with 0, 10, 50, and 250 mg/kg of silymarin once daily for 5 days.
Quanren, He +3 more
openaire +2 more sources
Evolving standards of care and new challenges in the management of HER2‐positive breast cancer
Ca-A Cancer Journal for Clinicians, 2020Grace M Choong +2 more
exaly
Treatment of renal cell carcinoma: Current status and future directions
Ca-A Cancer Journal for Clinicians, 2017Pedro Coelho Barata, Brian I Rini
exaly
Role of Transforming Growth Factor β in Human Disease
New England Journal of Medicine, 2000Gerard C Blobe
exaly
Angiogenesis Inhibitors: Current Strategies and Future Prospects
Ca-A Cancer Journal for Clinicians, 2010Kristina M Cook, William D Figg
exaly
Contextual determinants of TGFβ action in development, immunity and cancer
Nature Reviews Molecular Cell Biology, 2018Joan Massagué Solé
exaly
The Transforming Growth Factor-beta Family
Annual Review of Cell Biology, 1990Joan Massagué Solé
exaly

